HDM1002 200 mg QD 12weeks

DRUG2 trials

Sponsors

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Conditions

Glucagon-Like Peptide-1 Receptor AgonistsOverweight and Obesity

Phase 1

HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects

Not yet recruitingNCT06520540

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Glucagon-Like Peptide-1 Receptor Agonists

Start: 2024-07-28End: 2024-12-30Target: 72Updated: 2024-07-25

Phase 2

Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults

Not yet recruitingNCT06500299

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Overweight and Obesity

Start: 2024-07-15End: 2024-11-30Target: 180Updated: 2024-07-15

Related Papers

2609-P: Efficacy and Safety of a Novel Oral Small Molecule GLP-1 Receptor Agonist HDM1002 in Chinese Overweight and Obese Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

Diabetes2026-06-05